| JYHB2300191 | 氯沙坦钾氢氯噻嗪片 | hydrochlorothiazide;losartan potassium | Tablet | Chemical Drugs | Supplementary Application | 2023-03-24 | | N V Organon;Organon Pharma (UK) Ltd | | | view |
| JYHB0500079 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2005-03-28 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Completed-Pending Issued | 2006-04-04 | view |
| JYHB2101412 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2021-09-15 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JYHB2200112 | 氯沙坦钾氢氯噻嗪片 | hydrochlorothiazide;losartan potassium | Tablet | Chemical Drugs | Supplementary Application | 2022-03-03 | | N V Organon;Organon Pharma (UK) Ltd | | | view |
| CYHB2550159 | 氢氯噻嗪片 | hydrochlorothiazide | Tablet | Chemical Drugs | Supplementary Application | 2025-03-27 | | Cisen Pharmaceutical Co Ltd | | | view |
| JYHB0500849 | 缬沙坦氢氯噻嗪片 | hydrochlorothiazide;valsartan | Tablet | Chemical Drugs | Supplementary Application | 2005-12-21 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | Certificate Issued | 2007-03-02 | view |
| JYHB1800750 | 氯沙坦钾氢氯噻嗪片 | hydrochlorothiazide;losartan potassium | Tablet | Chemical Drugs | Supplementary Application | 2018-07-06 | | Merck Sharp & Dohme Ltd;Merck Sharp & Dohme BV | Certificate Issued | 2020-05-28 | view |
| CYHS2102155 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs(4) | Generic Drug | 2021-12-07 | | Jiangxi Shimei Pharmaceutical Co Ltd | | | view |
| CYHS2401079 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs(4) | Generic Drug | 2024-04-11 | | Jiangxi Shimei Pharmaceutical Co Ltd | | | view |
| CYHB2350443 | 替米沙坦氢氯噻嗪片 | hydrochlorothiazide;telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2023-05-16 | | Suzhou Chung- HWA Chemical & Pharmaceutical Industrial Co Ltd | | | view |
| CYHS2101567 | 奥美沙坦酯氢氯噻嗪片 | hydrochlorothiazide;olmesartan medoxomil | Tablet | Chemical Drugs(4) | Generic Drug | 2021-08-12 | | China Resources SAIKE Pharmaceutical Co Ltd | | | view |
| JXHL0600204 | 氯沙坦钾氢氯噻嗪片 | hydrochlorothiazide;losartan potassium | Tablet | Chemical Drugs(3.2) | Import Drug Application | 2006-08-04 | | Merck & Co Inc | Certificate Issued | 2007-08-03 | view |
| JYHB2101347 | 缬沙坦氢氯噻嗪片 | hydrochlorothiazide;valsartan | Tablet | Chemical Drugs | Supplementary Application | 2021-08-23 | | Novartis Farma SpA;Novartis Pharma Schweiz AG | | | view |
| JYHB0600737 | 缬沙坦氢氯噻嗪片 | hydrochlorothiazide;valsartan | Tablet | Chemical Drugs | Supplementary Application | 2006-11-01 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | Certificate Issued | 2007-04-26 | view |
| CYHS2101186 | 缬沙坦氢氯噻嗪片 | hydrochlorothiazide;valsartan | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-20 | | Zhe JIANG HUA HAI Pharmaceutical Co Ltd | | | view |
| CYHB2401550 | 奥美沙坦酯氢氯噻嗪片 | hydrochlorothiazide;olmesartan medoxomil | Tablet | Chemical Drugs | Supplementary Application | 2024-09-25 | | Daiichi Sankyo Pharmaceutical (SHANGHAI) Co Ltd | | | view |
| JYHZ2300356 | 替米沙坦氢氯噻嗪片 | hydrochlorothiazide;telmisartan | Tablet | Chemical Drugs | License Renew | 2023-09-04 | | Boehringer Ingelheim Hellas Single Member SA;Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH | | | view |
| CYHB2300295 | 奥美沙坦酯氢氯噻嗪片 | hydrochlorothiazide;olmesartan medoxomil | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-02-15 | | Shanghai Shyndec Pharmaceutical Co Ltd;Jilin Deshang Pharmaceutical Co Ltd | | | view |
| CYHS2201516 | 奥美沙坦酯氢氯噻嗪片 | hydrochlorothiazide;olmesartan medoxomil | Tablet | Chemical Drugs(4) | Generic Drug | 2022-09-14 | | Zhuhai Rundu Pharmaceutical Co Ltd | | | view |
| JYHB2200111 | 氯沙坦钾氢氯噻嗪片 | hydrochlorothiazide;losartan potassium | Tablet | Chemical Drugs | Supplementary Application | 2022-03-03 | | N V Organon;Organon Pharma (UK) Ltd | | | view |
